Reduction of ventricular arrhythmias by phosphocreatine (Neoton) in patients with acute myocardial infarction von Ruda, M.Ya, Samarenko, M.B., Afonskaya, N.I., Saks, V.A.

Volltext

Fibrinogen-immobilized Urokinase Demonstrates Increased Thrombolytic Activity in Animal Experiments von MAKSIMENKO, A. V., SAMARENKO, M. B., PETROV, A. D., TISCHENKO, E. G., RUDA, M. YA, TORCHILIN, V. P.

Volltext

Protection of ischemic myocardium by exogenous phosphocreatine (Neoton): Pharmacokinetics of phosphocreatine, reduction of infarct size, stabilization of sarcolemma of ischemic car... von Sharov, V.G., Afonskaya, N.I., Ruda, M.Y., Cherpachenko, N.M., Pozin, E.Ya, Markosyan, R.A., Shepeleva, I.I., Samarenko, M.B., Saks, V.A.

Volltext

Pharmacokinetics of serum phosphocreatine in man, dog, and rabbit von Afonskaya, N. I., Shepeleva, I. I., Anyukhovskii, E. P., Samarenko, M. B., Makhotina, L. A., Saks, V. A.

Volltext

Effectiveness of thrombolytic action of modified urokinase after bolus intravenous injection von Maksimenko, A. V., Samarenko, M. B., Petrov, A. D., Tishchenko, E. G., Abramova, V. V.

Volltext

Effects of a modified urokinase on the fibrinolytic system by intravenous bolus administration von Maksimenko, A. V., Samarenko, M. B., Dobrovol'skii, A. B., Petrov, A. D., Tischenko, E. G., Abramova, V. V.

Volltext